Major Companies in Thailand Omeprazole Market | Competitive Landscape 2026

Thailand Omeprazole Market Overview

According to 6Wresearch, the Thailand omeprazole market is experiencing steady growth, driven by a high prevalence of acid-related disorders and the success of the Universal Health Coverage (UHC) scheme. Omeprazole remains the first-line proton pump inhibitor (PPI) for treating gastric ulcers and GERD across the nation.
Furthermore, with Thai manufacturers increasingly securing PIC/S GMP certifications, the industry is expanding through exports to neighboring CLMV countries (Cambodia, Laos, Myanmar, and Vietnam), establishing Thailand as a regional hub for affordable, high-fidelity gastrointestinal therapies.

Competitive Landscape

The competitive landscape of the Thailand omeprazole market is characterized by severe competition between the state-owned GPO and private-sector giants. Domestic leaders maintain dominance by securing listings on the National List of Essential Medicines (NLEM), which guarantees high-volume hospital procurement, while simultaneously building strong brand equity in the retail over-the-counter (OTC) sector.

Below is a list of leading players operating in the Thailand Omeprazole Market:

1. The Government Pharmaceutical Organization (GPO)

The primary state enterprise responsible for providing mass-produced, low-cost omeprazole to the public healthcare system and rural clinics.

2. Siam Bheasach Co., Ltd.

A powerhouse in the generic segment, renowned for its "Miracid" brand, which is one of the most widely recognized and trusted omeprazole brands in Thai pharmacies.

3. Thai Nakorn Patana Co., Ltd.

Leverages its massive distribution network and "Sara" brand heritage to dominate the retail gastrointestinal market with high-resonance analgesic and antacid products.

4. Berlin Pharmaceutical Industry Co., Ltd.

A pioneer in branded generics, focusing on high-standard formulations for chronic disease management, including gastroesophageal reflux disease (GERD).

5. Biolab Co., Ltd.

A leading member of the Biopharm Group, Biolab specializes in PIC/S GMP-certified manufacturing and serves as a major OEM partner for global pharmaceutical brands.

6. Mega Lifesciences Public Company Limited

An international leader that markets a wide range of gastrointestinal and nutraceutical products across 35 countries, focusing on premium-quality capsules.

7. Siam Pharmaceutical Co., Ltd.

A veteran in the Thai market, supplying a comprehensive range of essential generic medicines to both public and private hospital sectors.

8. Millimed Co., Ltd.

Recognized for meeting international standards like JP-PMDA, Millimed produces various oral solid forms of omeprazole with a focus on regional exports.

9. Vesco Pharmaceutical Co., Ltd.

Specializes in the production of high-quality generic capsules and oral solutions for the local and Southeast Asian export markets.

10. AstraZeneca Ltd.

As the originator of Losec (the first omeprazole brand), AstraZeneca maintains a presence in the premium clinical sector for advanced acid-management cases.

11. T.P. Drug Laboratories Co., Ltd.

A long-standing manufacturer known for its reliability in the hospital procurement segment and its diverse portfolio of anti-inflammatory and gastro drugs.

12. Atlantic Laboratories Corporation

Manages a wide array of OTC and ethical medicines, serving as a significant contributor to the national pharmaceutical supply chain.

13. Olic (Thailand) Limited

A major contract manufacturer (CMO) providing high-quality production services for multinational pharmaceutical firms operating in the Thai market.